539 related items for PubMed ID: 109457
1. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
Lachelin GC, Yen SS.
J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
[Abstract] [Full Text] [Related]
2. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL, Wang CF, Yen SS.
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[Abstract] [Full Text] [Related]
3. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ, Kletzky OA, Brenner PF, Mishell DR.
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[Abstract] [Full Text] [Related]
4. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL, Katz M.
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[Abstract] [Full Text] [Related]
5. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
[Abstract] [Full Text] [Related]
6. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C, Vekemans M.
Acta Endocrinol (Copenh); 1976 Sep 01; 83(1):9-14. PubMed ID: 989226
[Abstract] [Full Text] [Related]
7. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA, Brenner PF, Kletzky OA, Mishell DR.
Am J Obstet Gynecol; 1978 Apr 01; 130(7):817-21. PubMed ID: 345817
[Abstract] [Full Text] [Related]
8. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
J Clin Endocrinol Metab; 1993 Aug 01; 77(2):420-6. PubMed ID: 8345046
[Abstract] [Full Text] [Related]
9. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U, Mashchak CA, Mishell DR.
Am J Obstet Gynecol; 1985 Apr 01; 151(7):868-77. PubMed ID: 3920910
[Abstract] [Full Text] [Related]
10. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
Jones GE, Wentz AC, Rosenwaks Z, Shoemaker J.
Am J Obstet Gynecol; 1977 Dec 01; 129(7):760-76. PubMed ID: 343592
[Abstract] [Full Text] [Related]
11. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
Wang CF, Lasley BL, Yen SS.
J Clin Endocrinol Metab; 1975 Jul 01; 41(1):41-3. PubMed ID: 1097463
[Abstract] [Full Text] [Related]
12. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K, Lunell NO, Zador G.
Gynecol Obstet Invest; 1978 Jul 01; 9(6):304-11. PubMed ID: 754992
[Abstract] [Full Text] [Related]
13. Anterior pituitary sensitivity in immature female rats stimulated with gonadotrophin releasing hormone in vivo: effect of priming with oestrogen, pregnant mare serum gonadotrophin or brain lesion.
De Ziegler D, Wilkinson M, Cassard D, Ruf KB.
J Endocrinol; 1977 Jul 01; 74(1):99-109. PubMed ID: 327011
[Abstract] [Full Text] [Related]
14. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
[Abstract] [Full Text] [Related]
15. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
Hemrika DJ, Slaats EH, Schoemaker J.
Am J Obstet Gynecol; 1994 Feb 01; 170(2):462-8. PubMed ID: 8116698
[Abstract] [Full Text] [Related]
16. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women.
Faure N, Labrie F, Olivier G, Tremblay M, Cloutier D, Lemay A, Ferland L, Azadian-Boulanger G, Bouton MM, Husson JM, Raynaud JP.
Maturitas; 1980 Jul 01; 2(2):155-68. PubMed ID: 6782429
[Abstract] [Full Text] [Related]
17. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus.
Yanaihara T, Arai K, Kanazawa M, Okinaga S, Yanaihara N, Yanaihara C.
Endocrinol Jpn; 1975 Dec 01; 22(6):525-30. PubMed ID: 782859
[Abstract] [Full Text] [Related]
18. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
Spellacy WN, Kalra PS, Buhi WC, Birk SA.
Am J Obstet Gynecol; 1980 May 01; 137(1):109-15. PubMed ID: 6768295
[Abstract] [Full Text] [Related]
19. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
Moss RL, McCann SM.
Neuroendocrinology; 1975 May 01; 17(4):309-18. PubMed ID: 806824
[Abstract] [Full Text] [Related]
20. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
van Heusden AM, Fauser BC.
Contraception; 1999 Apr 01; 59(4):237-43. PubMed ID: 10457868
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
